- $158.94m
- $30.47m
- $315.66m
- 45
- 64
- 77
- 66
Annual income statement for Inogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 362 | 308 | 358 | 377 | 316 |
| Cost of Revenue | |||||
| Gross Profit | 172 | 138 | 176 | 154 | 127 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 342 | 315 | 349 | 462 | 425 |
| Operating Profit | 19.8 | -6.72 | 9.24 | -85.2 | -109 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 24.3 | -5.28 | 8.66 | -83.3 | -102 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 20.9 | -5.83 | -6.33 | -83.8 | -102 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 20.9 | -5.83 | -6.33 | -83.8 | -102 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 20.9 | -5.83 | -6.33 | -83.8 | -102 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.973 | -0.417 | 0.054 | -1.74 | -3.69 |